Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
Multiple sclerosis and employment: Associations of psychological factors and work instability.
Anti-myelin oligodendrocyte glycoprotein antibody neuritis optica following anti-NMDA receptor encephalitis.
Therapeutic application of monoclonal antibodies in multiple sclerosis.
Arzerra receives approval in Japan
Journal Club: Effect of comorbidity on mortality in multiple sclerosis.
Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells.
Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.
Current trends in autoimmunity and the nervous system.
Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL/6 mice.
Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.
Normal Molecular Specification and Neurodegenerative Disease-Like Death of Spinal Neurons Lacking the SNARE-Associated Synaptic Protein Munc18-1.
Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.
Blockade of chemokine signaling in patients with multiple sclerosis.
The 5-HT₆ serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats.
CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.
Diffusivity in multiple sclerosis lesions: At the cutting edge?
Cognitive dysfunction and behavioral abnormalities in neuromyelitis optica spectrum disorder: report of a case with cortical gray matter involvement and frontotemporal atrophy.
Disease modifying therapies for relapsing multiple sclerosis.
Electrophysiological observations in critically ill Guillain-Barre syndrome.
Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-Sparing Potential.
Potential treatment mechanisms in a mindfulness-based intervention for people with progressive multiple sclerosis.
Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis.
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
The Corpus Callosum and Forensic Issues-An Overview.

Pages